Adaptive Biotechnologies Corp

Company Snapshot
1165 Eastlake Avenue East
Seattle, WA 98109
United States
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 619
Please select from the dropdown
Company Financials

2022
2023
2024
Gross Profit
$127,399,000
$94,723,000
$106,877,000
Operating Income
-$200,186,000
-$201,606,000
-$155,344,000
Net Income
-$200,191,000
-$225,250,000
-$159,492,000
2022
Gross Profit
$127,399,000
Operating Income
-$200,186,000
Net Income
-$200,191,000
2023
Gross Profit
$94,723,000
Operating Income
-$201,606,000
Net Income
-$225,250,000
2024
Gross Profit
$106,877,000
Operating Income
-$155,344,000
Net Income
-$159,492,000
The above data on Adaptive Biotechnologies Corp came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Chairman of the Board and Chief Executive Officer
$981,240
$7,900,711
$22,316
$8,904,267
$8,904,267
Chairman of the Board and Chief Executive Officer
Chief Scientific Officer
$706,162
$7,900,711
$4,932
$8,611,805
$8,611,805
Chief Scientific Officer
President and Chief Operating Officer
$716,108
$2,249,999
$4,932
$2,971,039
$2,971,039
President and Chief Operating Officer
Chief Commercial Officer, Immune Medicine
$626,406
$2,249,999
$4,316
$2,880,721
$2,880,721
Chief Commercial Officer, Immune Medicine
Lead Independent Director
$105,000
$249,996
$0
$354,996
$354,996
Lead Independent Director
Adaptive Biotechnologies Corp listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2023. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us